Aldeyra Therapeutics Inc
NASDAQ:ALDX 3:59:54 PM EDT
Earnings Announcements
Aldeyra Therapeutics Reports Full-Year 2021 Financial Results, Recent Corporate Highlights
Published: 03/17/2022 11:20 GMT
Aldeyra Therapeutics Inc (ALDX) - Aldeyra Therapeutics Reports Full-year 2021 Financial Results and Recent Corporate Highlights.
Aldeyra Therapeutics Inc - Reports Full-year 2021 Financial Results and Recent Corporate Highlights.
Aldeyra Therapeutics Inc - Cash and Cash Equivalents of $229.8 Million As of December 31, 2021; Projected Cash Runway Through 2023.
Aldeyra Therapeutics Inc - Reports Full-year 2021 Financial Results and Recent Corporate Highlights.
Aldeyra Therapeutics Inc - Cash and Cash Equivalents of $229.8 Million As of December 31, 2021; Projected Cash Runway Through 2023.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.30
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.33
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.30
Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.33
More details on our Analysts Page.